MELVILLE, N.Y.--(BUSINESS WIRE)--OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today its financial results for the Company's first quarter ended March 31, 2008. The Company reported net income from continuing operations of $31.7 million (or $0.52 per share) for the three months ended March 31, 2008, compared with net income from continuing operations of $19.7 million (or $0.33 per share) for the same period last year, an increase of 61%.
